Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LadRx Corp LADX

Healthcare Biotechnology
LadRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company focuses on the discovery, research and clinical development of anti-cancer drug candidates that employ technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities. The Company’s linker activated drug release (LADR) technology platform consists of an... see more

Recent & Breaking News (OTCQB:LADX)

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of CytRx Corporation Investors and Encourages Investors to Contact the Firm

Business Wire August 26, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of CytRx Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 23, 2016

Business Wire August 26, 2016

Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those with Losses from Investment in CytRx Corporation to Contact the Firm

Business Wire August 25, 2016

CYTR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving CytRx Corporation and a Lead Plaintiff Deadline of September 23, 2016

Business Wire August 22, 2016

SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against CytRx Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire August 17, 2016

CYTR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving CytRx Corporation and a Lead Plaintiff Deadline of September 23, 2016

GlobeNewswire August 17, 2016

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against CytRx Corporation and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

Business Wire August 17, 2016

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against CytRx Corporation and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

Business Wire August 15, 2016

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against CytRx Corporation

Business Wire August 15, 2016

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In CytRx Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline – CYTR

GlobeNewswire August 15, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CytRx Corporation of Class Action Lawsuit and Upcoming Deadline – CYTR

GlobeNewswire August 12, 2016

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of CytRx Corporation Investors and Encourages Investors to Contact the Firm

Business Wire August 12, 2016

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against CytRx Corporation and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm

Business Wire August 12, 2016

STOCK NOTICE: Rosen Law Firm Reminds CytRx Corporation Investors of Important Deadline in Class Action

Business Wire August 12, 2016

SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against CytRx Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire August 12, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of CytRx Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 23, 2016 – CYTR

GlobeNewswire August 12, 2016

Robbins Arroyo LLP: CytRx Corporation (CYTR) Misled Shareholders According to a Recently Filed Class Action

Business Wire August 11, 2016

INVESTOR ALERT: Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In CytRx Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline

Business Wire August 3, 2016

CytRx Corporation Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire August 3, 2016

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation

Marketwired August 1, 2016